General Information of Drug (ID: DM3BWTM)

Drug Name
DX-2500 Drug Info
Synonyms Anti-FcRn antibody (autoimmune disorder), Dyax Corp
Indication
Disease Entry ICD 11 Status REF
Ischemic heart disease BA40-BA6Z Investigative [1]
Cross-matching ID
TTD Drug ID
DM3BWTM

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rozanolixizumab DMK0NGB Generalized myasthenia gravis 8C60 Approved [2]
Nipocalimab DM0622O Myasthenia gravis 8C6Y Phase 3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Immunoglobulin Fc receptor (FCR) TTPY4SE NOUNIPROTAC Not Available [1]

References

1 Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates. Front Immunol. 2015; 6: 176.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals. Drugs. 2022 Jun;82(8):865-887.